Literature DB >> 33804381

Pathogen Dose in Animal Models of Hemorrhagic Fever Virus Infections and the Potential Impact on Studies of the Immune Response.

Bryce M Warner1.   

Abstract

Viral hemorrhagic fever viruses come from a wide range of virus families and are a significant cause of morbidity and mortality worldwide each year. Animal models of infection with a number of these viruses have contributed to our knowledge of their pathogenesis and have been crucial for the development of therapeutics and vaccines that have been approved for human use. Most of these models use artificially high doses of virus, ensuring lethality in pre-clinical drug development studies. However, this can have a significant effect on the immune response generated. Here I discuss how the dose of antigen or pathogen is a critical determinant of immune responses and suggest that the current study of viruses in animal models should take this into account when developing and studying animal models of disease. This can have implications for determination of immune correlates of protection against disease as well as informing relevant vaccination and therapeutic strategies.

Entities:  

Keywords:  Ebola virus; Lassa virus; T cells; Th1/Th2; animal model; hemorrhagic fever; hemorrhagic fever viruses; immune response; pathogen dose

Year:  2021        PMID: 33804381      PMCID: PMC7999429          DOI: 10.3390/pathogens10030275

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  183 in total

1.  Molecular characterization of a hamster viscerotropic strain of yellow fever virus.

Authors:  Monica A McArthur; Miguel T Suderman; John-Paul Mutebi; Shu-Yuan Xiao; Alan D T Barrett
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 2.  The Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  David Safronetz; Hideki Ebihara; Heinz Feldmann; Jay W Hooper
Journal:  Antiviral Res       Date:  2012-06-15       Impact factor: 5.970

3.  Pathogenesis of experimental Crimean hemorrhagic fever infection in newborn white mice.

Authors:  S E Smirnova; G L Zubri; A P Savinov; M P Chumakov
Journal:  Acta Virol       Date:  1973-09       Impact factor: 1.162

4.  The original haemorrhagic fever: yellow fever.

Authors:  L H Dennis; B E Reisberg; J Crosbie; D Crozier; M E Conrad
Journal:  Br J Haematol       Date:  1969-11       Impact factor: 6.998

5.  The role of the Type I interferon response in the resistance of mice to filovirus infection.

Authors:  Mike Bray
Journal:  J Gen Virol       Date:  2001-06       Impact factor: 3.891

6.  Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody.

Authors:  Chad E Mire; Joan B Geisbert; Viktoriya Borisevich; Karla A Fenton; Krystle N Agans; Andrew I Flyak; Daniel J Deer; Herta Steinkellner; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Andrew Hiatt; Do H Kim; Michael H Pauly; Jesus Velasco; Kevin J Whaley; James E Crowe; Larry Zeitlin; Thomas W Geisbert
Journal:  Sci Transl Med       Date:  2017-04-05       Impact factor: 17.956

7.  Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory.

Authors:  N Jaax; P Jahrling; T Geisbert; J Geisbert; K Steele; K McKee; D Nagley; E Johnson; G Jaax; C Peters
Journal:  Lancet       Date:  1995 Dec 23-30       Impact factor: 79.321

8.  Kyasanur Forest disease virus infection in mice is associated with higher morbidity and mortality than infection with the closely related Alkhurma hemorrhagic fever virus.

Authors:  Kimberly A Dodd; Brian H Bird; Megan E B Jones; Stuart T Nichol; Christina F Spiropoulou
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

9.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Authors:  Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger
Journal:  Nature       Date:  2014-08-29       Impact factor: 49.962

10.  Kyasanur Forest disease virus non-mouse animal models: a pilot study.

Authors:  A M Nikiforuk; K Tierny; T A Cutts; D K Kobasa; S S Theriault; B W M Cook
Journal:  BMC Res Notes       Date:  2020-06-15
View more
  1 in total

1.  Livestock and Risk Group 4 Pathogens: Researching Zoonotic Threats to Public Health and Agriculture in Maximum Containment.

Authors:  Charles E Lewis; Bradley Pickering
Journal:  ILAR J       Date:  2022-01-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.